Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2009 Jan 9;284(2):792–798. doi: 10.1074/jbc.M806954200

Extracellular Protons Regulate Human ENaC by Modulating Na+ Self-inhibition*

Daniel M Collier 1, Peter M Snyder 1,1
PMCID: PMC2613628  PMID: 18990692

Abstract

The epithelial Na+ channel, ENaC, is exposed to a wide range of proton concentrations in the kidney, lung, and sweat duct. We, therefore, tested whether pH alters ENaC activity. In Xenopus oocytes expressing human α-, β-, and γENaC, amiloride-sensitive current was altered by protons in the physiologically relevant range (pH 8.5-6.0). Compared with pH 7.4, acidic pH increased ENaC current, whereas alkaline pH decreased current (pH50 = 7.2). Acidic pH also increased ENaC current in H441 epithelia and in human primary airway epithelia. In contrast to human ENaC, pH did not alter rat ENaC current, indicating that there are species differences in ENaC regulation by protons. This resulted predominantly from species differences in γENaC. Maneuvers that lock ENaC in a high open-probability state (“DEG” mutation, proteolytic cleavage) abolished the effect of pH on human ENaC, indicating that protons alter ENaC current by modulating channel gating. Previous work showed that ENaC gating is regulated in part by extracellular Na+ (“Na+ self-inhibition”). Based on several observations, we conclude that protons regulate ENaC by altering Na+ self-inhibition. First, protons reduced Na+ self-inhibition in a dose-dependent manner. Second, ENaC regulation by pH was abolished by removing Na+ from the extracellular bathing solution. Third, mutations that alter Na+ self-inhibition produced corresponding changes in ENaC regulation by pH. Together, the data support a model in which protons modulate ENaC gating by relieving Na+ self-inhibition. We speculate that this may be an important mechanism to facilitate epithelial Na+ transport under conditions of acidosis.


The epithelial Na+ channel, composed of three homologous subunits (α-, β-, and γENaC), functions as a pathway for Na+ reabsorption across epithelia in the kidney collecting duct, lung, distal colon, and sweat duct (for review, see Refs. 1 and 2). In this role the channel is critical for the maintenance of Na+ homeostasis and to control the composition and quantity of the fluid on the apical membrane of these epithelia. ENaC mutations and defects in its regulation cause inherited forms of hypertension and hypotension (3) and may contribute to the pathogenesis of lung disease in cystic fibrosis (4).

As a member of the DEG/ENaC family of ion channels, ENaC shares common structural and functional features with channels that are gated by diverse stimuli. All DEG/ENaC subunits share a common overall structure, with two transmembrane domains and relatively short cytoplasmic N and C termini, leaving the majority of the protein exposed as a large extracellular domain (5). Differences in these extracellular domains between DEG/ENaC family members result in dramatic functional diversity, from mechanosensitive ion channels in Caenorhabditis elegans (6) to ligand-gated channels such as the peptide (FMRF-amide)-gated FaNaCh channel in mollusks (7) and proton-gated ASIC channels (8, 9).

Although no analogous ligand has yet been identified for ENaC, it is clear that the extracellular domain is important in modulating ENaC activity. For example, proteolytic cleavage at two sites in the extracellular domains of α- and γENaC convert channels from an inactive to an active state (1012). One population of channels is cleaved by furin in the Golgi complex (11). A second population reaches the cell surface in an uncleaved state and is susceptible to cleavage and activation by proteases at the cell surface and in the extracellular fluid (1215). Other molecules in the extracellular fluid also modulate ENaC gating. Extracellular Na+ inhibits ENaC activity through a process called Na+ self-inhibition, which serves as a negative feedback mechanism to regulate Na+ transport (1618). Two observations implicate a role for the extracellular domain in Na+ self-inhibition. First, mutations of conserved histidine residues in the extracellular domains of α- and γENaC alter Na+ self-inhibition (18). Second, proteolytic cleavage of the extracellular domain prevents Na+ self-inhibition (19). Divalent cations including Zn2+ and Ni2+ are also thought to alter ENaC activity by binding to the extracellular domain (20, 21).

These findings suggest that the extracellular domain might function as a sensor to allow a variety of signals in the extracellular environment to modulate ENaC activity. In this regard protons are a strong candidate to regulate ENaC. In its location at the apical membrane of epithelia, ENaC is exposed to extremes of pH. For instance, urine pH in the collecting duct can vary from 4.5 to 8 in response to metabolic acidosis and alkalosis as well as with changes in diet and volume status (22). Normal airway surface liquid pH is slightly alkaline (pH 7.8–8.1) (23) but can become highly acidic (pH 4–6) with lung disease (24). Sweat pH can fall to <6 when the production rate is low but becomes neutral as production increases (25).

Although ENaC appears poised to respond to changes in pH, previous studies investigating this possibility have been conflicting. External pH < 5 decreased short-circuit current in frog skin (26) but increased Na+ transport in toad bladder (27). In cultured Xenopus collecting duct cells (A6), acidification of the extracellular medium (pH 6.4 and 5.4) produced a slow increase in amiloride-sensitive current that peaked at ∼30 min (28). More recent work investigated the role of external pH in regulation of rat α-, β-, and γENaC expressed in Xenopus oocytes. These studies reported a very small transient increase (28), small decrease (pH 4.0) (29), or no change in current (30, 31). When α- and βENaC were coexpressed without γENaC, acidic pH inhibited the channel (which has an open-probability close to 1.0) (30). Moreover, an additional subunit, δENaC, was activated by acidic pH (29, 32), although this subunit is not expressed in renal epithelia. Together the data suggest that pH modulates epithelial Na+ transport, but the magnitude and direction of the regulation may vary in different tissues and species. To further explore this possibility and to understand the mechanisms by which pH regulates Na+ transport, we tested the effect of protons on the activity of human ENaC.

EXPERIMENTAL PROCEDURES

DNA Constructs—cDNAs for human and rat α-, β-, and γENaC in pMT3 were cloned as previously described (33, 34). Mutations in αENaC (H255R) and γENaC (H233R) were generated by site-directed mutagenesis (QuikChange; Stratagene) and sequenced in the University of Iowa DNA Core.

Expression and Whole-cell Electrophysiology in Xenopus Oocytes—Oocytes were harvested from albino Xenopus laevis females and manually defolliculated after a 1-h treatment with 0.75 mg/ml type IV collagenase (Sigma) in Ca2+ free ND-96 (96 mm NaCl, 2 mm KCl, 1 mm MgCl2, 5 mm HEPES, pH adjusted to 7.4 with NaOH). After nuclear injection of cDNAs encoding human or rat α-, β-, and γENaC (0.02 μg/μl each), cells were incubated at 18 °C in modified Barth's saline (88 mm NaCl, 1 mm KCl, 0.33 mm Ca(NO3)2, 0.41 mm CaCl2, 0.82 mm MgSO4, 2.4 mm NaHCO3, 10 mm HEPES, 50 μg/ml gentamycin sulfate, 10 μg/ml sodium penicillin, 10 μg/ml streptomycin sulfate, pH adjusted to 7.4 with NaOH) for 20–24 h before the study.

Oocytes were voltage-clamped (two-electrode voltage clamp), and currents were amplified with an Oocyte Clamp OC-725C (Warner Instruments), digitized with a MacLab/200 interface (ADInstruments), and recorded and analyzed with Chart software (ADInstruments). Unless otherwise noted, recordings were done at –60 mV in a 116 mm NaCl solution (116 mm NaCl, 2 mm KCl, 0.4 mm CaCl2, 1 mm MgCl2, 5 mm HEPES, pH adjusted to 7.4 with NaOH). Low Na+ solutions (0 or 1 mm NaCl, 116 or 115 mm N-Methyl-d-glucamine chloride) were used as indicated in the figure legends (Figs. 5 and 6). The pH of test solutions (8.5–5.5) was adjusted with HCl or NaOH. Amiloride-sensitive current was determined by adding 10 μm amiloride to the bathing solution. The pH-induced change in amiloride-sensitive current was calculated as the -fold increase/decrease relative to the pH 7.4 base line just before each test solution application. This was done to reduce the effect of time-dependent current run-down. The resulting data were plotted and fit to the Hill equation using IGOR Pro software (WaveMetrics Inc.). Na+ self-inhibition was measured by rapidly changing the bathing solution from low sodium (1 mm NaCl) to high sodium (116 mm NaCl) and quantitated as (peak current (IP) – steady state current (Iss))/peak current (IP).

FIGURE 5.

FIGURE 5.

Extracellular pH modulates Na+ self-inhibition. A, representative current trace from Xenopus oocyte expressing humanαβγ ENaC (–60 mV). The extracellular bath pH was 7.4 unless otherwise indicated by black bars. The bath was rapidly changed from 1 to 116 mm NaCl (at pH 8.5 or 6.5) to observe the degree of Na+ self-inhibition. Peak current (IP) and steady-state current (ISS) are indicated. 10 μm amiloride (Amil) was added to quantitate ENaC current. B, plot of Na+ self-inhibition of amiloride-sensitive current ((IPISS)/IP) at pH 8.5–6.5 (mean ± S.E., n = 14). C, plot of peak amiloride-sensitive current after a shift in bathing solution from 1 to 116 mm NaCl measured at pH 8.5–6.5 (relative to peak current at pH 7.4) (mean ± S.E., n = 14). D,Na+ self-inhibition induced by shift from 0 mm Na+ to 1–116 mm Na+ (plotted on the x axis) at pH 8.5, 7.4, and 6.5 (mean ± S.E., n = 3–5). Data are fit to the Hill equation; R2 = 0.9984 (pH 8.5), 0.9998 (pH 7.4), and 0.9991 (pH 6.5).

FIGURE 6.

FIGURE 6.

Regulation by extracellular pH requires Na+. A and B, representative current traces from Xenopus oocytes expressing human αβγ ENaC voltage-clamped at +30 mV. Extracellular bathing solution contained 1 mm Na+ (A) or 116 mm Na+ (B). Extracellular pH was changed from pH 7.4 (open bars) to pH 8.5 and 6.5 (black bars) as indicated. In panel B, the gray line indicates time-dependent drift in outward amiloride (Amil)-insensitive current. C, plot of -fold change in amiloride-sensitive current at pH 8.5 and 6.5 (relative to pH 7.4 (IpH xIpH 7.4)/IpH 7.4). Inward currents were studied in 116 mm Na+ at –60 mV (n = 37), and outward currents were studied in 116 or 1 mm Na+ at +30 mV (n = 9 and 14, respectively) (mean ± S.E., *, p < 0.0001 versus 116 mm Na+ at –60 or +30 mV by Student's t test).

Expression and Whole-cell Electrophysiology in H441 and Primary Airway Epithelia—H441 cells (American Type Culture Collection) were grown on 0.6-cm2 permeable filter supports (Millipore) in RPMI with 8.5% fetal calf serum, 20 mm l-glutamine, 5 μg/ml insulin, 5 μg/ml transferrin, 5 ng/ml selenium, 100 nm dexamethasone, 100 units/ml penicillin, and 100 μg/ml streptomycin at 37 °C for 5 days. Primary human airway epithelia were isolated from the trachea and bronchi of donor lungs and grown at the air-liquid interface of collagen-coated permeable filter supports as described previously (35). Aprotinin (26 μg/ml) was present in the apical solution for 2 h before study. Short-circuit Na+ current was measured in modified Ussing chambers (Warner Instrument Corp.) using an EC-825 Epithelial Voltage Clamp amplifier (Warner). Currents were digitized with a PowerLab interface (ADInstruments) and recorded and analyzed with Chart software (ADInstruments). The apical and basolateral surfaces were bathed in 116 mm NaCl, 2 mm KCl, 0.4 mm CaCl2, 1 mm MgCl2, 5 mm HEPES (pH 7.4 basolateral, 7.4 or 6.5 apical) at 37 °C. Amiloride-sensitive short-circuit current was determined as the difference in current with and without amiloride (10 μm) in the apical bathing solution.

RESULTS

pH Changes Alter ENaC Current—To determine whether changes in extracellular pH alter ENaC current, we expressed human α-, β-, and γENaC in Xenopus oocytes and recorded Na+ current at a holding potential of –60 mV. In Fig. 1A, we found that current was reduced when we shifted the extracellular pH from 7.4 to 8.5. Conversely, pH 6.5 increased current. The changes in current were rapidly reversible on returning to pH 7.4. When ENaC was blocked by amiloride, changes in pH did not alter current, indicating that pH regulated ENaC and not an endogenous oocyte current. Also consistent with this conclusion, pH changes from 8.5 to 5.5 did not significantly alter current in uninjected oocytes (not shown). Fig. 1B shows the pH dose-response relationship for amiloride-sensitive ENaC current (relative to current at pH 7.4). Current was maximal at pH 6 (I6/I7.4 = 1.4 ± .0148) and minimal at pH 8.5 (I8.5/I7.4 = 0.8 ± .01), with a pH50 of 7.2. Thus, human ENaC current is regulated by pH within the range found in the kidney collecting duct and other epithelia.

FIGURE 1.

FIGURE 1.

Extracellular protons modulate human ENaC current. A, representative trace of current versus time recorded in Xenopus oocyte expressing human αβγ ENaC at holding potential of –60 mV. The extracellular bath was changed from pH 7.4 (open bars) to pH 8.5 and 6.5 (black bars) with or without 10 μm amiloride (black bars) as indicated. B, amiloride-sensitive current for human ENaC (relative to current at pH 7.4) with bathing solution pH varied from 8.5 to 5.5 (mean ± S.E., n = 37; error bars are hidden by the symbols). Data are fit to the Hill equation (R2 = 0.9991).

In Figs. 2, A and B, we tested the effect of pH on amiloride-sensitive current in epithelia that express endogenous ENaC. In a human lung carcinoma cell line (H441), amiloride-sensitive current was larger at pH 6.5 than at pH 7.4 (Fig. 2, A and C). Results were similar in primary cultures of human airway epithelia (Fig. 2, B and C). pH 6.5 increased ENaC current in both epithelia to an extent similar to that when ENaC was expressed in Xenopus oocytes (Fig. 2C). These data indicate that shifts in pH alter ENaC current not only in heterologous cells but also in Na+-transporting epithelia.

FIGURE 2.

FIGURE 2.

Extracellular protons modulate Na+ transport in epithelia. A and B, representative short-circuit current traces from H441 (A) and primary human airway (B) epithelia. pH changes and the addition of amiloride (Amil) to the apical bathing solution (10 μm) are indicated by the bars. 0.5-mV pulses were applied every 15 s to monitor resistance. C, percent increase in amiloride-sensitive current in response to pH 6.5 (compared with pH 7.4) for H441 epithelia (n = 6), primary airway epithelia (n = 6), and oocytes expressing human αβγ ENaC (n = 37) (mean ± S.E.). The asterisk indicates that the change in amiloride-sensitive current at pH 6.5 (compared with pH 7.4) is statistically significant (p < 0.001 for H441, p < 0.003 for airway, and p < 0.0001 for oocytes by Student's t test).

Species Specificity of pH Regulation—In contrast to human ENaC, rat ENaC currents were not altered by pH changes over the range 8.5–6 in Xenopus oocytes (Fig. 3, A and B). This finding suggests that pH regulates ENaC in a species-specific manner. To determine which subunit(s) underlies this species specificity, we substituted one of the human ENaC subunits in the channel complex with a rat subunit. Channels composed of human α- and γENaC with rat βENaC had a pH dose-response relationship similar to human ENaC (Fig. 3B). In contrast, pH failed to alter current when rat γENaC was expressed with human α- and βENaC (Fig. 3B). When rat αENaC was expressed with human β- and γENaC, pH altered ENaC current, although the effect of pH was reduced (Fig. 3B). Together the data indicate that sequence differences in γENaC (and perhaps αENaC) underlie the observed species variation in ENaC regulation by protons.

FIGURE 3.

FIGURE 3.

Species specificity of pH regulation. A, representative trace of current versus time recorded in Xenopus oocyte expressing rat αβγ ENaC at holding potential of –60 mV. The extracellular bath was changed from pH 7.4 (open bars) to pH 8.5 and 6.5 (black bars). 10 μm amiloride (black bar) was added to the bathing solution as indicated. B, amiloride-sensitive current for human (H) or rat (R) ENaC or the indicated combinations of two human and one rat subunit (relative to current at pH 7.4) with bathing solution pH varied from 8.5 to 6 (mean ± S.E., n = 5–37; error bars are hidden by the symbols). The Hill equation was used to fit the data for human (R2 = 0.9991), human βγ rat α (R2 = 0.9962), and human αγ rat β (R2 = 0.9995).

pH Regulates ENaC Gating—To determine the biophysical mechanism by which pH alters ENaC current, we took advantage of a strategy that prevents changes in ENaC gating. Covalent modification of a cysteine introduced at the DEG position in the external pore (βS520C) locks ENaC in an open conformation (open probability 0.96) (36). When βS520C was coexpressed with α- and γENaC in Xenopus oocytes, pH altered current to a similar extent as wild-type ENaC (Fig. 4, A and D). In contrast, after modification of the channel with [2-(trimethylammonium)-ethyl]methanethiosulfonate bromide (MTSET), changes in pH had a minimal effect on ENaC current (Fig. 4, B and D). As a second approach to address this question, we activated channels at the cell surface by proteolytic cleavage with trypsin, which dramatically increases ENaC open probability (12). After incubation with trypsin, changes in pH failed to alter ENaC current (Fig. 4, C and D). Together the data suggest that pH regulates ENaC by altering channel gating and argues against effects of pH on single channel conductance or channel number.

FIGURE 4.

FIGURE 4.

pH regulates ENaC gating. A and B, representative current traces at holding potential of –60 mV from the same Xenopus oocyte expressing human αβS520Cγ ENaC before (A) and after (B) covalent modification with 1 mm [2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) for 2 min. C, representative current trace at holding potential of –60 mV from a Xenopus oocyte expressing wild-type human αβγENaC after proteolytic cleavage by trypsin (2 μg/ml for 2 min). In AC, pH changes are indicated by open (pH 7.4) or black (pH 8.5 or 6.5) bars. 10 μm amiloride (Amil) was present in bathing solution, as indicated by the black bars. D, -fold change in amiloride-sensitive current in response to pH 8.5 or 6.5 (relative to current at pH 7.4) before and after application of MTSET (n = 5) or trypsin (n = 7) to oocytes expressing human αβS520Cγ or αβγ ENaC, respectively (mean ± S.E.). The asterisk indicates that the difference between the current at pH 6.5, and the current at pH 8.5 (I6.5I8.5) is statistically different between the indicated groups (p < 0.001).

Extracellular pH Modulates Na+ Self-inhibition—Previous work indicates that extracellular Na+ regulates ENaC gating, a mechanism known as Na+ self-inhibition. The representative traces in Fig. 5A illustrate this regulation. A shift in extracellular Na+ from 1 to 116 mm induced a peak inward current (IP) that rapidly decreased to a lower steady state level (ISS). This decline in current reflects inhibition of ENaC by Na+. Proteolytic cleavage activates ENaC by preventing Na+ self-inhibition (19). Because we found that cleavage abolished the effect of pH on ENaC, we hypothesized that pH might regulate ENaC gating by altering Na+ self-inhibition. To test this hypothesis, we varied the extracellular pH and quantitated the fraction of ENaC current that was inhibited by Na+ after a shift from 1 to 116 mm Na+. We found that Na+ self-inhibition was pH-dependent. At acidic pH (6.5), a smaller fraction of amiloride-sensitive current was inhibited by Na+ than at alkaline pH (8.5), resulting in an increase in steady state current at pH 6.5 (Fig. 5, A and B). In contrast to its effect on steady state current, pH had no effect on the peak current induced by the shift in Na+ concentration (Fig. 5, A and C).

Protons could inhibit Na+ self-inhibition by reducing binding of Na+ to ENaC. To investigate this possibility, we determined dose-response relationships for Na+ self-inhibition at pH 8.5, 7.4, and 6.5 (fit to the Hill equation). In Fig. 5D we shifted the extracellular Na+ from 0 mm to concentrations between 1 and 116 mm. At pH 7.4 Na+ produced a dose-dependent increase in self-inhibition; half-maximal inhibition (Ki) occurred at 44.9 ± 1.6 mm Na+, and the maximum fraction of current inhibited by Na+ was 0.57 ± 0.01. pH 6.5 decreased the maximal effect of Na+ (0.49 ± 0.03), but it had no effect on the sensitivity of ENaC to Na+ (Ki = 44.7 ± 4.8). pH 8.5 had the opposite effect, increasing the maximal effect of Na+ (0.66 ± 0.05) with no effect on sensitivity (Ki = 43.5 ± 5.4). Thus, pH modulates Na+ self-inhibition by altering the maximal effect of Na+ on ENaC without affecting its sensitivity to Na+.

Regulation by Extracellular pH Requires Sodium—If pH regulates ENaC by modulating Na+ self-inhibition, then the pH effect should be dependent on the presence of Na+ in the extracellular solution. To test this prediction, we measured outward amiloride-sensitive currents (holding potential +30 mV) with 1 or 116 mm Na+ in the bathing solution. In 1 mm Na+, pH had a negligible effect on ENaC current (Fig. 6, A and C). In contrast, in 116 mm Na+, pH 8.5 reduced and pH 6.5 increased outward ENaC current (Fig. 6, B and C), similar to the effect of pH on inward currents with 116 mm Na+ (Fig. 6C, compare black bars to open bars). Thus, extracellular Na+ is required for pH to regulate ENaC. In addition, these results indicate that pH regulates ENaC independent of voltage and the direction of Na+ movement.

Mutations That Alter Na+ Self-inhibition also Affect pH Regulation—Previous work identified two ENaC histidine residues critical for Na+ self-inhibition (18). Mutation of His-239 in mouse γENaC (His-233 in human) abolished self-inhibition, whereas mutation of the equivalent residue in αENaC (mouse His-282, which is His-255 in human) increased self-inhibition. To test if these mutations alter the effect of pH on ENaC current, we expressed αH255RβγENaC or αβγH233R ENaC in Xenopus oocytes. γH233R nearly abolished the effect of pH on ENaC current (Fig. 7, A and C). Conversely, αH255R increased the degree of ENaC activation by acidic pH (compared with wild-type ENaC), although it had no effect at alkaline pH (Fig. 7, B and C). Thus, mutation of γENaC abolished both Na+ self-inhibition and ENaC regulation by pH, whereas both properties were increased by mutation of αENaC. This correlation together with our other data supports a model in which pH alters ENaC current by modulating Na+ self-inhibition.

FIGURE 7.

FIGURE 7.

Mutations that alter Na+ self-inhibition affect pH regulation. A and B, representative current traces at holding potential of –60 mV from Xenopus oocytes expressing human αβγH233R ENaC (A) or αH255Rβγ ENaC (B). The extracellular bath was changed from pH 7.4 (open bars) to pH 8.5 and 6.5 (black bars) with or without 10 μm amiloride (Amil, black bars) as indicated. C, amiloride-sensitive current for wild-type or mutant ENaC (relative to current at pH 7.4) with bathing solution pH varied from 8.5 to 5.5 (mean ± S.E., n = 21–37; some error bars are hidden by the symbols). Data are fit to the Hill equation; R2 = 0.9992 (αH255Rβγ), 0.8767 (αβγH233R), and 0.9991 (wild type).

DISCUSSION

Our data indicate that the activity of human ENaC is modulated by changes in extracellular pH; acidic pH increased activity, whereas alkaline pH reduced activity. pH changes altered ENaC gating; by relieving Na+ self-inhibition, protons increased ENaC open-probability.

How does pH alter Na+ self-inhibition? We hypothesize that protons titrate one or more ENaC residues that alter the response to Na+. This could occur through two general mechanisms. First, it is possible that protons reduce Na+ binding to the extracellular domain. However, our finding that pH changes did not alter the Ki for Na+ self-inhibition argues against this model, as it indicates that protons do not alter the affinity of Na+ for ENaC. Thus, it is unlikely that protons titrate residues that form the Na+ binding site. Second, pH could function downstream of Na+ binding, altering the transduction of Na+ binding into changes in ENaC gating. Consistent with this model, we found that protons increased the maximal effect of Na+ on ENaC current.

What residues are titrated by protons? We found that the effect of pH on ENaC current was independent of voltage and on the direction of current flow, which indicates that protons do not alter ENaC current by titrating residues in its pore. Thus, it is likely protons titrate one or more residues in extracellular domain. The recent crystal structure of ASIC1 identified H+ binding sites located at the interface between the finger and thumb domains of this related channel (37). Movement of the thumb domain relative to the finger domain was proposed to underlie channel gating. Although the ASIC1 H+ binding residues are not well conserved in ENaC, we speculate that the interface between the finger and thumb domains has a conserved role in modulating channel activity and participates in H+ binding to ENaC. Consistent with this idea, residues that modulate ENaC function are located at this interface. For example, proteolytic cleavage activates ENaC by removal of part of the finger domain. Moreover, the α- and γENaC histidines important for Na+ self-inhibition (αH255R and γH233R) are located at the finger-thumb interface. However, it seems unlikely that protons regulate ENaC by titrating these histidines, as the αH255R and γH233R mutations had opposite effects on pH modulation of ENaC current. In addition, these histidines are conserved in rat ENaC, which did not respond to changes in pH.

As a related question, which ENaC subunits mediate the pH sensitivity of ENaC? Do protons bind to all three subunits or only a subset of subunits? Our data implicate a role for γENaC, as substitution of rat in place of human γENaC abolished channel regulation by protons. Substitution of the α subunit had a partial effect on pH regulation, suggesting that residues in αENaC may also contribute. In contrast, substitution of βENaC did not alter ENaC regulation by protons. This situation is somewhat analogous to ENaC regulation by proteolytic cleavage, where ENaC is regulated by cleavage of the extracellular domains of α- and γENaC but not βENaC (11). However, our current data do not exclude a role for βENaC; it is possible that human and rat βENaC share conserved H+ binding sites. The species difference in pH regulation suggests a strategy to identify residues that contribute to this regulation. The extracellular domain of human γENaC contains a large number of potential targets for protons that are not present in rat ENaC (14 histidines and acidic residues), and there are 10 in αENaC. Based on analogy to ASIC1 (37, 38), we speculate that titration of multiple residues contributes to pH regulation of human ENaC.

How can we reconcile our current results with previous conflicting data in the literature? First, there appear to be species differences in ENaC regulation by pH. Although pH altered human ENaC current, it had no effect on rat ENaC in the range we tested, consistent with previous work. From a comparative physiology perspective, we do not yet know why pH regulates ENaC in some species but not others. In humans, differences in diet can produce wide variations in urine pH. For example, consumption of meat produces an acidic urine, whereas vegetarians have an alkaline urine. Perhaps rats lacked selective pressure to develop or retain the pH response because of a less varied diet. Conflicting data may also arise from differences in the proteolytic cleavage state of ENaC in various experimental systems. We found that proteolytic cleavage (trypsin) abolished the effect of pH on human ENaC. Thus, the response to pH is influenced by the cleavage state of the channel. Under conditions where the majority of ENaC is fully cleaved, the response to pH will be blunted.

ENaC is exposed to extreme changes in pH. Coupled with our data showing that pH alters ENaC current, this suggests that pH may be an important regulator of epithelial Na+ transport. What is the physiological role of this regulation? In the kidney-collecting duct, it is well described that there is an interdependence between Na+ absorption and H+ secretion; Na+ absorption generates a transmembrane voltage which increases H+ secretion (39, 40). Perhaps activation of ENaC by protons facilitates secretion of an acid load. In this regard it is interesting that the Na+-absorbing principal cells are located next to intercalated cells, which are responsible for H+ secretion. This suggests a potential model in which protons function as a paracrine signal to regulate Na+ absorption. In the lung it is possible that acidic airway fluid stimulates ENaC to remove liquid from the lung in conditions such as pneumonia and pulmonary edema.

Acknowledgments

We thank Diane Olson and Kaela Kramer for assistance and acknowledge the University of Iowa In Vitro Models and Cell Culture Core for providing primary airway cultures and the University of Iowa DNA Core Facility for reagents and DNA sequencing.

*

This work was supported, in whole or in part, by a National Institutes of Health grant (to P. M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

References

  • 1.Schild, L. (2004) Rev. Physiol. Biochem. Pharmacol. 151 93–107 [DOI] [PubMed] [Google Scholar]
  • 2.Snyder, P. M. (2005) Endocrinology 146 5079–5085 [DOI] [PubMed] [Google Scholar]
  • 3.Lifton, R. P. (1996) Science 272 676–680 [DOI] [PubMed] [Google Scholar]
  • 4.Boucher, R. C., Stutts, M. J., Knowles, M. R., Cantley, L., and Gatzy, J. T. (1986) J. Clin. Investig. 78 1245–1252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Snyder, P. M., McDonald, F. J., Stokes, J. B., and Welsh, M. J. (1994) J. Biol. Chem. 269 24379–24383 [PubMed] [Google Scholar]
  • 6.Tavernarakis, N., and Driscoll, M. (1997) Annu. Rev. Physiol. 59 659–689 [DOI] [PubMed] [Google Scholar]
  • 7.Lingueglia, E., Champigny, G., Lazdunski, M., and Barbry, P. (1995) Nature 378 730–733 [DOI] [PubMed] [Google Scholar]
  • 8.Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski, M. (1997) Nature 386 173–177 [DOI] [PubMed] [Google Scholar]
  • 9.Price, M. P., Snyder, P. M., and Welsh, M. J. (1996) J. Biol. Chem. 271 7879–7882 [DOI] [PubMed] [Google Scholar]
  • 10.Vallet, V., Chraibi, A., Gaeggeler, H. P., Horisberger, J. D., and Rossier, B. C. (1997) Nature 389 607–610 [DOI] [PubMed] [Google Scholar]
  • 11.Hughey, R. P., Bruns, J. B., Kinlough, C. L., Harkleroad, K. L., Tong, Q., Carattino, M. D., Johnson, J. P., Stockand, J. D., and Kleyman, T. R. (2004) J. Biol. Chem. 279 18111–18114 [DOI] [PubMed] [Google Scholar]
  • 12.Caldwell, R. A., Boucher, R. C., and Stutts, M. J. (2004) Am. J. Physiol. 286 C190–C194 [DOI] [PubMed] [Google Scholar]
  • 13.Hughey, R. P., Bruns, J. B., Kinlough, C. L., and Kleyman, T. R. (2004) J. Biol. Chem. 279 48491–48494 [DOI] [PubMed] [Google Scholar]
  • 14.Knight, K. K., Olson, D. R., Zhou, R., and Snyder, P. M. (2006) Proc. Natl. Acad. Sci. U. S. A. 103 2805–2808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Adebamiro, A., Cheng, Y., Rao, U. S., Danahay, H., and Bridges, R. J. (2007) J. Gen. Physiol. 130 611–629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Garty, H., and Palmer, L. G. (1997) Physiol. Rev. 77 359–396 [DOI] [PubMed] [Google Scholar]
  • 17.Chraibi, A., and Horisberger, J. D. (2002) J. Gen. Physiol. 120 133–145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sheng, S., Bruns, J. B., and Kleyman, T. R. (2004) J. Biol. Chem. 279 9743–9749 [DOI] [PubMed] [Google Scholar]
  • 19.Sheng, S., Carattino, M. D., Bruns, J. B., Hughey, R. P., and Kleyman, T. R. (2006) Am. J. Physiol. 290 F1488–F1496 [DOI] [PubMed] [Google Scholar]
  • 20.Sheng, S., Perry, C. J., and Kleyman, T. R. (2002) J. Biol. Chem. 277 50098–50111 [DOI] [PubMed] [Google Scholar]
  • 21.Sheng, S., Perry, C. J., and Kleyman, T. R. (2004) J. Biol. Chem. 279 31687–31696 [DOI] [PubMed] [Google Scholar]
  • 22.Rose, B. D. (1984) Clinical Physiology of Acid-Base and Electrolyte Disorders, pp. 225–247, McGraw-Hill Inc., New York
  • 23.Paget-Brown, A. O., Ngamtrakulpanit, L., Smith, A., Bunyan, D., Hom, S., Nguyen, A., and Hunt, J. F. (2006) Chest 129 426–430 [DOI] [PubMed] [Google Scholar]
  • 24.Hunt, J. (2007) Immunol. Allergy Clin. North Am. 27 597–606; vi [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kaiser, D., Songo-Williams, R., and Drack, E. (1974) Pfluegers Arch. 349 63–72 [DOI] [PubMed] [Google Scholar]
  • 26.Levi, H., and Ussing, H. H. (1949) Nature 164 928. [DOI] [PubMed] [Google Scholar]
  • 27.Leaf, A., Keller, A., and Dempsey, E. F. (1964) Am. J. Physiol. 207 547–552 [DOI] [PubMed] [Google Scholar]
  • 28.Awayda, M. S., Boudreaux, M. J., Reger, R. L., and Hamm, L. L. (2000) Am. J. Physiol. 279 C1896–C1905 [DOI] [PubMed] [Google Scholar]
  • 29.Ji, H. L., and Benos, D. J. (2004) J. Biol. Chem. 279 26939–26947 [DOI] [PubMed] [Google Scholar]
  • 30.Zhang, P., Fyfe, G. K., Grichtchenko, I. I., and Canessa, C. M. (1999) Biophys. J. 77 3043–3051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chalfant, M. L., Denton, J. S., Berdiev, B. K., Ismailov, II, Benos, D. J., and Stanton, B. A. (1999) Am. J. Physiol. 276 C477–C486 [DOI] [PubMed] [Google Scholar]
  • 32.Yamamura, H., Ugawa, S., Ueda, T., Nagao, M., and Shimada, S. (2004) J. Biol. Chem. 279 12529–12534 [DOI] [PubMed] [Google Scholar]
  • 33.McDonald, F. J., Snyder, P. M., McCray, P. B., Jr., and Welsh, M. J. (1994) Am. J. Physiol. 266 L728–L734 [DOI] [PubMed] [Google Scholar]
  • 34.McDonald, F. J., Price, M. P., Snyder, P. M., and Welsh, M. J. (1995) Am. J. Physiol. 268 C1157–C1163 [DOI] [PubMed] [Google Scholar]
  • 35.Karp, P. H., Moninger, T. O., Weber, S. P., Nesselhauf, T. S., Launspach, J. L., Zabner, J., and Welsh, M. J. (2002) Methods Mol. Biol. 188 115–137 [DOI] [PubMed] [Google Scholar]
  • 36.Snyder, P. M., Bucher, D. B., and Olson, D. R. (2000) J. Gen. Physiol. 116 781–790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Jasti, J., Furukawa, H., Gonzales, E. B., and Gouaux, E. (2007) Nature 449 316–323 [DOI] [PubMed] [Google Scholar]
  • 38.Paukert, M., Chen, X., Polleichtner, G., Schindelin, H., and Grunder, S. (2008) J. Biol. Chem. 283 572–581 [DOI] [PubMed] [Google Scholar]
  • 39.Al-awqati, Q., Mueller, A., and Steinmetz, P. R. (1977) Am. J. Physiol. 233 F502–F508 [DOI] [PubMed] [Google Scholar]
  • 40.Batlle, D. C. (1986) Metabolism 35 852–860 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES